Cargando…
Epidermal growth factor receptor inhibitor therapy for recurrent respiratory papillomatosis
The epidermal growth factor pathway has been implicated in various tumors, including human papillomavirus (HPV) lesions such as recurrent respiratory papillomatosis (RRP). Due to the presence of epidermal growth factor receptors in RRP, epidermal growth factor receptor (EGFR) inhibitors have been ut...
Autores principales: | Moldan, Matthew M., Bostrom, Bruce C, Tibesar, Robert J, Lander, Timothy A., Sidman, James D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999927/ https://www.ncbi.nlm.nih.gov/pubmed/24795806 http://dx.doi.org/10.12688/f1000research.2-202.v1 |
Ejemplares similares
-
Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis
por: Avelino, Melissa Ameloti Gomes, et al.
Publicado: (2015) -
Recurrent respiratory papillomatosis with lung involvement
por: Molodtsova, Valentina, et al.
Publicado: (2018) -
Recurrent respiratory papillomatosis: the role of cidofovir
por: Tran, Mai Ngoc, et al.
Publicado: (2018) -
Sleep and Speech Outcomes After Superior Adenoidectomy in Children with Cleft Palate
por: Waselchuk, Emily, et al.
Publicado: (2018) -
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis
por: MOHR, MICHAEL, et al.
Publicado: (2014)